Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications
- PMID: 32133288
- PMCID: PMC7039860
- DOI: 10.3389/fonc.2020.00137
Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications
Abstract
Lung cancer mortality represents the leading cause of cancer related deaths in the United States and worldwide. Almost half of these deaths occur in female patients, making lung cancer the most common cause of cancer mortality in women with a higher annual mortality rate than breast, uterine, and ovarian cancers combined. The distinct epidemiological, histological and biological presentation of non-small cell lung cancer (NSCLC) in women combined with extensive preclinical data have demonstrated that the female sex hormone β-estradiol (E2) plays an important role in NSCLC tumorigenesis, prognosis, and treatment response. Estrogen receptors are widely expressed on stromal and immune cells, and estrogen-linked signaling pathways are known to be involved in regulating the response of both the innate and adaptive immune system. Immune evasion has been recognized as a "hallmark" of cancer and immunotherapy has re-defined standard of care treatment for NSCLC. Despite these advancements, the low response rates observed in patients treated with immune checkpoint inhibitors has led to a search for mediators of immunosuppression and ways to augment the action of these agents. We focus on emerging data describing sex differences that modulate immunotherapy efficacy in NSCLC, immunosuppressive properties of E2 that lead to a pro-tumor microenvironment (TME), and the translational potential of altering the immune microenvironment by targeting the estrogen signaling pathway. E2-induced modulation affects multiple cell types within the TME, including cancer-associated fibroblasts, tumor infiltrating myeloid cells, and tumor infiltrating lymphocytes, all of which interplay with lung tumor cells via E2 and estrogen receptor engagement, ultimately shaping the TME that may, in part, be responsible for the sex-based disparities observed in NSCLC. An improved understanding of the role of the estrogen pathway in NSCLC anti-cancer immunity may lead to novel therapeutic approaches for altering the TME to improve the efficacy of immunotherapy agents.
Keywords: NSCLC; anti-tumor immunity; estrogen; immune checkpoint inhibitors; sex disparities; tumor microenvironment.
Copyright © 2020 Smida, Bruno and Stabile.
Figures
Similar articles
-
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7. Cancer Treat Rev. 2020. PMID: 32682248 Review.
-
The Impact of Estrogen in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1277:33-52. doi: 10.1007/978-3-030-50224-9_2. Adv Exp Med Biol. 2020. PMID: 33119863
-
Influence of estrogen in non-small cell lung cancer and its clinical implications.J Thorac Dis. 2018 Jan;10(1):482-497. doi: 10.21037/jtd.2017.12.61. J Thorac Dis. 2018. PMID: 29600083 Free PMC article. Review.
-
The estrogen pathway as a modulator of response to immunotherapy.Immunotherapy. 2019 Sep;11(13):1161-1176. doi: 10.2217/imt-2019-0024. Epub 2019 Jul 30. Immunotherapy. 2019. PMID: 31361169 Review.
-
The Role of the Estrogen Pathway in the Tumor Microenvironment.Int J Mol Sci. 2018 Feb 19;19(2):611. doi: 10.3390/ijms19020611. Int J Mol Sci. 2018. PMID: 29463044 Free PMC article. Review.
Cited by
-
Cytoplasmic expression of G protein-coupled estrogen receptor 1 correlates with poor postoperative prognosis in non-small cell lung cancer.J Thorac Dis. 2022 May;14(5):1466-1477. doi: 10.21037/jtd-22-29. J Thorac Dis. 2022. PMID: 35693608 Free PMC article.
-
Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective.Cancers (Basel). 2021 Dec 24;14(1):80. doi: 10.3390/cancers14010080. Cancers (Basel). 2021. PMID: 35008242 Free PMC article. Review.
-
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.Front Cell Dev Biol. 2021 Jun 23;9:652599. doi: 10.3389/fcell.2021.652599. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34249910 Free PMC article.
-
Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression.Int J Biol Sci. 2023 Jul 16;19(12):3709-3725. doi: 10.7150/ijbs.84577. eCollection 2023. Int J Biol Sci. 2023. PMID: 37564195 Free PMC article.
-
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer.Front Oncol. 2023 Mar 24;13:1108124. doi: 10.3389/fonc.2023.1108124. eCollection 2023. Front Oncol. 2023. PMID: 37035182 Free PMC article.
References
-
- American Cancer Society Cancer Facts and Figures 2019. Atlanta, GA: (2019).
Publication types
LinkOut - more resources
Full Text Sources